Refine
Has Fulltext
- yes (24) (remove)
Is part of the Bibliography
- yes (24) (remove)
Year of publication
Document Type
- Doctoral Thesis (24)
Keywords
- Biofilm (24) (remove)
Institute
- Institut für Molekulare Infektionsbiologie (10)
- Graduate School of Life Sciences (4)
- Institut für Hygiene und Mikrobiologie (4)
- Fakultät für Biologie (2)
- Abteilung für Funktionswerkstoffe der Medizin und der Zahnheilkunde (1)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (1)
- Klinik und Polikliniken für Zahn-, Mund- und Kieferkrankheiten (1)
- Lehrstuhl für Orthopädie (1)
- Poliklinik für Zahnerhaltung und Parodontologie (1)
- Theodor-Boveri-Institut für Biowissenschaften (1)
Sonstige beteiligte Institutionen
Avian pathogenic Escherichia coli (APEC) represent a subset of the so-called extraintestinal pathogenic Escherichia coli (ExPEC) pathotype that can cause various extraintestinal infections in humans and animals. APEC are the causative agent of localized colibacillosis or systemic infection in poultry. In this latter case, the syndrome starts as an infection of the upper respiratory tract and develops into a systemic infection. Generally, ExPEC are characterized by a broad variety of virulence-associated factors that may contribute to pathogenesis. Major virulence factors, however, that clearly define this pathotype, have not been identified. Instead, virulence-associated genes of ExPEC and thus also of APEC could be used in a mix-and-match-fashion. Both pathotypes could not be clearly distinguished by molecular epidemiology, and this suggested a hypothetical zoonotic risk caused by APEC. Accordingly, the main scientific question of this study was to characterize common traits as well as differences of APEC and human ExPEC variants that could either support the possible zoonotic risk posed by these pathogenic E. coli strains or indicate factors involved in host specificity. Comparative genomic analysis of selected APEC and human ExPEC isolates of the same serotype indicated that these variants could not be clearly distinguished on the basis of (i) general phenotypes, (ii) phylogeny, (iii) the presence of typical ExPEC virulence genes, and (iv) the presence of pathoadaptive mutations. Allelic variations in genes coding for adhesins such as MatB and CsgA or their regulators MatA and CsgD have been observed, but further studies are required to analyze their impact on pathogenicity. On this background, the second part of this thesis focused on the analysis of differences between human ExPEC and APEC isolates at the gene expression level. The analysis of gene expression of APEC and human ExPEC under growth conditions that mimick their hosts should answer the question whether these bacterial variants may express factors required for their host-specificity. The transcriptomes of APEC strain BEN374 and human ExPEC isolate IHE3034 were compared to decipher whether there was a specific or common behavior of APEC and human ExPEC, in response to the different body temperatures of man (37°C) or poultry (41°C). Only a few genes were induced at 41 °C in each strain relative to growth at 37 °C. The group of down-regulated genes in both strains was markedly bigger and mainly included motility and chemotaxis genes. The results obtained from the transcriptome, genomic as well as phenotypic comparison of human ExPEC and APEC, supports the idea of a potential zoonotic risk of APEC and certain human ExPEC variants. In the third part of the thesis, the focus was set on the characterization of Mat fimbriae, and their potential role during ExPEC infection. Comparison of the mat gene cluster in K-12 strain MG1655 and O18:K1 isolate IHE3034 led to the discovery of differences in (i) DNA sequence, (ii) the presence of transcriptional start and transcription factor binding sites as well as (iii) the structure of the matA upstream region that account for the different regulation of Mat fimbriae expression in these strains. A negative role of the H-NS protein on Mat fimbriae expression was also proven at 20 °C and 37 °C by real-time PCR. A major role of this fimbrial adhesin was demonstrated for biofilm formation, but a significant role of Mat fimbriae for APEC in vivo virulence could not yet be determined. Interestingly, the absence of either a functional matA gene or that of the structural genes matBCDEF independently resulted in upregulation of motility in E. coli strains MG1655 and IHE3034 by a so far unknown mechanism. In conclusion, the results of this thesis indicate a considerable overlap between human and animal ExPEC strains in terms of genome content and phenotypes. It becomes more and more apparent that the presence of a common set of virulence-associated genes among ExPEC strains as well as similar virulence gene expression patterns and phylogenetic backgrounds indicate a significant zoonotic risk of avian-derived E. coli isolates. In addition, new virulence factors identified in human ExPEC may also play a role in the pathogenesis of avian ExPEC.
Das Gram-positive, Koagulase-negative Bakterium Staphylococcus epidermidis war viele Jahrzehnte als harmloser Kommensale der menschlichen Haut und der Schleimhäute bekannt. Jedoch hat sich S. epidermidis in den letzten zwanzig Jahren zu einem Haupterreger von Nosokomialinfektionen entwickelt. Dabei unterscheidet sich S. epidermidis im Vergleich zu anderen Erregern durch ein sehr begrenztes Spektrum an Pathogenitätsfaktoren, aber auch durch seine Fähigkeit, Biofilme auf künstlichen Oberflächen wie Kathetern und Implantaten formen zu können. Die vorliegende Arbeit beschäftigt sich mit zwei Hauptaspekten, die in der Pathogenität von S. epidermidis eine wichtige Rolle spielen: (i) dem Quorum-sensing System Agr (accessory gene regulator) und (ii) dem zeitlichen Prozess des Aufbaus, sowie der Regulation der Biofilmbildung von S. epidermidis. Das Quorum-sensing System Agr ist Teil eines komplexen regulatorischen Netzwerks. In der vorliegenden Arbeit wird durch Proteom- und Transkriptomanalysen gezeigt, dass das Agr-System in S._epidermidis den Hauptregulator für die Sekretion von extrazellulären Proteinen darstellt und darüber hinaus einen großen Einfluss auf die Regulation des Zentralmetabolismus und der Biosynthese von Aminosäuren hat. Mittels Mikroarray-Analyse konnte eine wichtige Verknüpfung des Agr-Systems mit dem pleiotrophen Repressor CodY identifiziert werden, der viele stationäre-Phase Gene im S._epidermidis Wildtyp reprimiert, jedoch nicht in der getesteten agr Mutante. Dieses führt zu einem stark veränderten Phänotyp der S. epidermidis agr Mutante, in Hinblick auf Wachstumskapazität, der Biofilmbildung, der Invasivität und dem Langzeitüberleben. Interessanterweise ergaben wissenschaftliche Studien, dass ca. 17 % der klinischen Isolate natürlich vorkommende agr Mutanten sind. Dieses könnte ein Hinweis darauf sein, dass S. epidermidis agr Mutanten aufgrund ihres stark veränderten Phänotyps und ihrer veränderten biochemischen Bedürfnisse und Kapazität in der Lage sind, andere ökologische Nischen im menschlichen Wirt zu besiedeln. Der zweite Teil dieser Arbeit hat die Biofilmbildung von S. epidermidis zum Thema. Durch die Etablierung eines standardisierten Modells der Biofilmbildung, war es möglich, über die Einführung einer Biofilm-Adhäsion-Ratio die Biofilmbildung als zeitlichen dynamischen Prozess darzustellen und verschiedenste Bedingungen und Stämme miteinander zu vergleichen. Dabei zeigte sich, dass die Biofilmbildung in S._epidermidis ein klar zeitlich strukturierter Prozess ist, der von Umweltfaktoren und der Nährstoffsituation abhängig ist, und dass verschiedene Stämme sehr unterschiedlich auf Veränderungen in ihrer Umwelt reagieren. Die zeitliche Analyse der Biofilmbildung mittels konfokaler Lasermikroskopie ergab, dass viele der Bakterien im Biofilm sterben. Dieses macht den Biofilm wesentlich anfälliger für Strömungsscherkräfte, die dann ganze Bakterienverbände ablösen und zu neuen Infektionsherden schwemmen könnten. Somit ermöglicht der Tod einer einzelnen Zelle unter Umständen ein besseres klonales Überleben. Die Mikroarray-Analysen der Genexpression im Biofilm zeigten, dass dieser einen physiologisch klar definierten Prozess durchläuft, der zu einer sehr stark verminderten metabolischen Aktivität und einer erhöhten Antibiotika-Resistenz führt. Darüber hinaus zeigen Bakterien im Biofilm einen weniger aggressiven Charakter, wie die Expression von Proteasen oder anderer Pathogenitätsfaktoren, welches S. epidermidis dabei hilft, dem Immunsystem des Wirts zu entgehen. Diese neuen Ergebnisse zur Regulation der Genexpression im Biofilm und zur Rolle des Quorum-sensing Systems Agr in S. epidermidis tragen wesentlich zum Verständnis der Pathogenität und der Physiologie dieses wichtigen nosokomialen Erregers bei. Sie bilden eine wichtige theroretische Grundlage für weiterführende Studien, mit dem Ziel in Zukunft neue Therapie- und Präventionsansätze gegen S. epidermidis-Infektionen zu entwickeln.
Marine sponge-associated actinomycetes are reservoirs of diverse natural products with novel biological activities. Their antibiotic potential has been well explored against a range of Gram positive and negative bacteria. However, not much is known about their anti-infective or anti-virulence potential against human pathogens. This Ph.D. project aimed to investigate the anti-infective (anti-Shiga toxin and anti-biofilm) potential of sponge-derived actinobacteria through identification and isolation of their bioactive metabolites produced and characterizing their mechanism of action by transcriptomics. This thesis is divided into three studies with the overall objective of exploring the anti-infective efficacy of actinomycetes-derived extracts and compound(s) that could possibly be used as future therapeutics.
The first study deals with investigation on the anti-Shiga toxin effects of sponge-associated actinomycetes. Diarrheal infections pose a huge burden in several developing and developed countries. Diarrheal outbreaks caused by Enterohemorrhagic Escherichia coli (EHEC) could lead to life-threatening complications like gastroenteritis and haemolytic uremic syndrome (HUS) if left untreated. Shiga toxin (Stx) produced by EHEC is a major virulence factor that negatively affects the human cells, leading them to death via apoptosis. Antibiotics are not prescribed against EHEC infections since they may enhance the risk of development of HUS by inducing the production and release of Stx from disintegrating bacteria and thereby, worsening the complications. Therefore, an effective drug that blocks the Stx production without affecting the growth needs to be urgently developed. In this study, the inhibitory effects of 194 extracts and several compounds originating from a collection of marine sponge-derived actinomycetes were evaluated against the Stx production in EHEC strain EDL933 with the aid of Ridascreen® Verotoxin ELISA assay kit. It was found that treatment with the extracts did not lead to significant reduction in Stx production. However, strepthonium A isolated from the culture of Streptomyces sp. SBT345 (previously cultivated from the Mediterranean sponge Agelas oroides) reduced the Stx production (at 80 μM concentration) in EHEC strain EDL933 without affecting the bacterial growth. The structure of strepthonium A was resolved by spectroscopic analyses including 1D and 2D-NMR, as well as ESI-HRMS and ESI-HRMS2 experiments. This demonstrated the possible application of strepthonium A in restraining EHEC infections.
VI
In the second study, the effect of marine sponge-associated actinomycetes on biofilm formation of staphylococci was assessed. Medical devices such as contact lenses, metallic implants, catheters, pacemakers etc. are ideal ecological niches for formation of bacterial biofilms, which thereby lead to device-related infections. Bacteria in biofilms are multiple fold more tolerant to the host immune responses and conventional antibiotics, and hence are hard-to-treat. Here, the anti-biofilm potential of an organic extract derived from liquid fermentation of Streptomyces sp. SBT343 (previously cultivated from the Mediterranean sponge Petrosia ficiformis) was reported. Results obtained in vitro demonstrated its anti-biofilm (against staphylococci) and non-toxic nature (against mouse macrophage (J774.1), fibroblast (NIH/3T3) and human corneal epithelial cell lines). Interestingly, SBT343 extract could inhibit staphylococcal biofilm formation on polystyrene, glass and contact lens surfaces without affecting the bacterial growth. High Resolution Fourier Transform Mass Spectrometry (HR-MS) analysis indicated the complexity and the chemical diversity of components present in the extract. Preliminary physio-chemical characterization unmasked the heat stable and non-proteinaceous nature of the active component(s) in the extract. Finally, fractionation experiments revealed that the biological activity was due to synergistic effects of multiple components present in the extract.
In the third study, anti-biofilm screening of 50 organic extracts generated from solid and liquid fermentation of 25 different previously characterized sponge-derived actinomycetes was carried out. This led to identification of the anti-biofilm organic extract derived from the solid culture of Streptomyces sp. SBT348 (previously cultivated from the Mediterranean sponge Petrosia ficiformis). Bioassay-guided fractionation was employed to identify the active fraction Fr 7 in the SBT348 crude extract. Further purification with semi-preparative HPLC led to isolation of the bioactive SKC1, SKC2, SKC3, SKC4 and SKC5 sub-fractions. The most active sub-fraction SKC3 was found to be a pure compound having BIC90 and MIC values of 3.95 μg/ml and 31.25 μg/ml against S. epidermidis RP62A. SKC3 had no apparent toxicity in vitro on cell lines and in vivo on the greater wax moth Galleria melonella larvae. SKC3 was stable to heat and enzymatic treatments indicating its non-proteinaceous nature. HR-MS analysis revealed the mass of SKC3 to be 1258.3 Da. Structure elucidation of SKC3 with the aid of 1D and 2D-NMR data is currently under investigation. Further, to obtain insights into the mode of action of SKC3 on S. epidermidis RP62A, RNA sequencing was done. Transcriptome data revealed that SKC3 was recognized by RP62A at 20 min and SKC3 negatively interfered with the central metabolism of staphylococci at 3 h. Taken
VII
together, these findings suggest that SKC3 could be a lead structure for development of new anti-staphylococcal drugs.
Overall, the results obtained from this work underscore the anti-infective attributes of actinomycetes consortia associated with marine sponges, and their applications in natural product drug discovery programs.
Staphylococcus aureus (SA) causes nosocomial infections including life threatening sepsis by multi-resistant strains (MRSA). It has the ability to form biofilms to protect it from the host immune system and from anti staphylococcal drugs. Biofilm and planctonic life style is regulated by a complex Quorum-Sensing (QS) system with agr as a central regulator. To study biofilm formation and QS mechanisms in SA a Boolean network was build (94 nodes, 184 edges) including two different component systems such as agr, sae and arl. Important proteins such as Sar, Rot and SigB were included as further nodes in the model. System analysis showed there are only two stable states biofilm forming versus planctonic with clearly different subnetworks turned on. Validation according to gene expression data confirmed this. Network consistency was tested first according to previous knowledge and literature. Furthermore, the predicted node activity of different in silico knock-out strains agreed well with corresponding micro array experiments and data sets. Additional validation included the expression of further nodes (Northern blots) and biofilm production compared in different knock-out strains in biofilm adherence assays. The model faithfully reproduces the behaviour of QS signalling mutants. The integrated model allows also prediction of various other network mutations and is supported by experimental data from different strains. Furthermore, the well connected hub proteins elucidate how integration of different inputs is achieved by the QS network. For in silico as well as in vitro experiments it was found that the sae-locus is also a central modulator of biofilm production. Sae knock-out strains showed stronger biofilms. Wild type phenotype was rescued by sae complementation. To elucidate the way in which sae takes influence on biofilm formation the network was used and Venn-diagrams were made, revealing nodes regulated by sae and changed in biofilms. In these Venn-diagrams nucleases and extracellular proteins were found to be promising nodes. The network revealed DNAse to be of great importance. Therefore qualitatively the DNAse amount, produced by different SA mutants was measured, it was tried to dissolve biofilms with according amounts of DNAse and the concentration of nucleic acids, proteins and polysaccharides were measured in biofilms of different SA mutants.
With its thorough validation the network model provides a powerful tool to study QS and biofilm formation in SA, including successful predictions for different knock-out mutant behaviour, QS signalling and biofilm formation. This includes implications for the behaviour of MRSA strains and mutants. Key regulatory mutation combinations (agr–, sae–, sae–/agr–, sigB+, sigB+/sae–) were directly tested in the model but also in experiments. High connectivity was a good guide to identify master regulators, whose detailed behaviour was studied both in vitro and in the model. Together, both lines of evidence support in particular a refined regulatory role for sae and agr with involvement in biofilm repression and/or SA dissemination. With examination of the composition of different mutant biofilms as well as with the examination of the reaction cascade that connects sae to the biofilm forming ability of SA and also by postulating that nucleases might play an important role in that, first steps were taken in proving and explaining regulatory links leading from sae to biofilms. Furthermore differences in biofilms of different mutant SA strains were found leading us in perspective towards a new understanding of biofilms including knowledge how to better regulate, fight and use its different properties.